Kirby RS - Search Results

1

A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates.

Foley CL, Bott SR, Thomas K, Parkinson MC, Kirby RS. Foley CL, et al. Among authors: kirby rs. BJU Int. 2003 Sep;92(4):370-4. doi: 10.1046/j.1464-410x.2003.04361.x. BJU Int. 2003. PMID: 12930421

2

Avoidance and management of positive surgical margins before, during and after radical prostatectomy.

Bott SR, Kirby RS. Bott SR, et al. Among authors: kirby rs. Prostate Cancer Prostatic Dis. 2002;5(4):252-63. doi: 10.1038/sj.pcan.4500612. Prostate Cancer Prostatic Dis. 2002. PMID: 12627209 Review.

3

Prostate cancer management: (1) an update on localised disease.

Bott SR, Birtle AJ, Taylor CJ, Kirby RS. Bott SR, et al. Among authors: kirby rs. Postgrad Med J. 2003 Oct;79(936):575-80. doi: 10.1136/pmj.79.936.575. Postgrad Med J. 2003. PMID: 14612600 Free PMC article. Review.

4

Counting the cost of treating benign prostatic hyperplasia.

Foley CL, Taylor C, Kirby RS. Foley CL, et al. Among authors: kirby rs. BJU Int. 2004 Feb;93(3):250-2. doi: 10.1111/j.1464-410x.2004.04595.x. BJU Int. 2004. PMID: 14764116 No abstract available.

5

Allelic imbalance and biochemical outcome after radical prostatectomy.

Bott SR, Masters JR, Parkinson MC, Kirby RS, Feneley M, Hooper J, Williamson M. Bott SR, et al. Among authors: kirby rs. Prostate Cancer Prostatic Dis. 2006;9(2):160-8. doi: 10.1038/sj.pcan.4500862. Epub 2006 Mar 14. Prostate Cancer Prostatic Dis. 2006. PMID: 16534511

6

Benign prostatic hyperplasia: solutions to an ageing problem.

Foley CL, Bott SR, Arya M, Kirby RS. Foley CL, et al. Among authors: kirby rs. Hosp Med. 2002 Aug;63(8):460-4. doi: 10.12968/hosp.2002.63.8.1965. Hosp Med. 2002. PMID: 12212416 Review.

7

5 alpha-reductase inhibitors: what's new?

Foley CL, Kirby RS. Foley CL, et al. Among authors: kirby rs. Curr Opin Urol. 2003 Jan;13(1):31-7. doi: 10.1097/00042307-200301000-00006. Curr Opin Urol. 2003. PMID: 12490813 Review.

8

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.

Nariculam J, Freeman A, Bott S, Munson P, Cable N, Brookman-Amissah N, Williamson M, Kirby RS, Masters J, Feneley M. Nariculam J, et al. Among authors: kirby rs. Asian J Androl. 2009 Jan;11(1):109-18. doi: 10.1038/aja.2008.22. Epub 2008 Dec 1. Asian J Androl. 2009. PMID: 19050681 Free PMC article.

9

Acute urinary retention: what is the impact on patients' quality of life?

Thomas K, Oades G, Taylor-Hay C, Kirby RS. Thomas K, et al. Among authors: kirby rs. BJU Int. 2005 Jan;95(1):72-6. doi: 10.1111/j.1464-410X.2004.05254.x. BJU Int. 2005. PMID: 15638898

10

Ki-67 expression in early prostate cancer and associated pathological lesions.

Feneley MR, Young MP, Chinyama C, Kirby RS, Parkinson MC. Feneley MR, et al. Among authors: kirby rs. J Clin Pathol. 1996 Sep;49(9):741-8. doi: 10.1136/jcp.49.9.741. J Clin Pathol. 1996. PMID: 9038759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters